PFE Jan 2024 55.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.9000

+0.0500

(+5.88%)

As of 03:21PM EST. Market open.

Loading interactive chart…

Yahoo Finance Video
Pharma earnings: COVID ‘is highly uncertain for this year,’ analyst says
Wells Fargo Managing Director Mohit Bansal joins Yahoo Finance Live to discuss pharmaceutical earnings amid COVID uncertainty, the impact of diabetic weight loss drugs on the market, and the outlook for drugmakers.
Motley Fool
Got $1,000? 3 Cheap Stocks To Buy Right Now
We may be entering a period of prolonged leadership from undervalued stocks, with these tickers poised to lead the charge.
Motley Fool
Pfizer's Sales Could Sink 33% in 2023. Here's Why to Buy the Stock Anyway.
Pfizer (NYSE: PFE) enjoyed a record year in 2022. The big drugmaker's revenue topped $100 billion. Its earnings per share soared 42% to $5.47, which translates to nearly $31.4 billion in profits. Both top- and bottom-line numbers set all-time highs.